CRISPR/Cas9 genome editing of hot-spot ELANE mutations in iPSCs of severe Congenital neutropenia patients

被引:0
|
作者
Nasri, M. [1 ]
Dannenmann, B. [1 ]
Ritter, M. [1 ]
Xu, Y. [1 ]
Klimiankou, M. [1 ]
Zeidler, C. [2 ]
Lengerke, C. [1 ]
Welte, K. [3 ]
Skokowa, J. [1 ]
机构
[1] Univ Klinikum Tubingen, Dept Oncol Hematol Immunol Rheumatol & Pulmonol, Tubingen, Germany
[2] Hannover Med Sch, Hematol Oncol, SCNER, Hannover, Germany
[3] Univ Klinikum Tubingen, Dept Pediat Hematol Oncol & Bone Marrow Transplan, Tubingen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ep698
引用
收藏
页码:195 / 195
页数:1
相关论文
共 50 条
  • [1] CRISPR/Cas9 mediated gene editing of ELANE enables neutrophilic maturation of primary HSPCs and iPSCs of severe congenital neutropenia patients
    Nasri, M.
    Dannenmann, B.
    Ritter, M.
    Mir, P.
    Amend, D.
    Xu, Y.
    Klimiankou, M.
    Zeidler, C.
    Kanz, L.
    Welte, K.
    Skokowa, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 236 - 236
  • [2] CRISPR/Cas9 Strategy for Correcting ELANE Mutations and Restoring Neutrophil Differentiation in Severe Congenital Neutropenia: Insights from Patient-Derived iPSCs
    Rydzynska, Zuzanna
    Grzela, Dawid
    Linder, Monika I.
    Dobrewa, Weronika
    Urbanska, Zuzanna
    Pawlik, Bartlomiej
    Krzyzanowski, Damian
    Mazurek, Maciej
    Janczar, Szymon
    Madzio, Joanna
    Mlynarski, Wojciech
    BLOOD, 2023, 142
  • [3] A Universal CRISPR/Cas9n-Mediated Genome Editing Approach for ELANE-Related Severe Congenital Neutropenia
    Nasri, Masoud
    Ritter, Malte Ulrich
    Mir, Perihan
    Dannenmann, Benjamin
    Kaufmann, Masako Monika
    Xu, Yun
    Borbaran-Bravo, Natalia
    Klimiankou, Maksim
    Lengerke, Claudia
    Zeidler, Cornelia
    Cathomen, Toni
    Welte, Karl
    Skokowa, Julia
    BLOOD, 2023, 142
  • [4] Gene Therapy Approach for Severe Congenital Neutropenia by CRISPR/Cas9 Gene-Editing of Hematopoietic Stem Cells and iPSCs
    Skokowa, Julia
    Ritter, Malte
    Nasri, Masoud
    Mir, Perihan
    Dannenmann, Benjamin
    Klimiankou, Maksim
    Aghaallaei, Nargessadat
    Secker, Benjamin
    Haaf, Jeremy
    Bravo, Natalia Alejandra Borbaran
    Zeidler, Cornelia
    Bajoghli, Baubak
    Xu, Yun
    Welte, Karl
    MOLECULAR THERAPY, 2020, 28 (04) : 166 - 167
  • [5] MILESTONE, A universal CRISPR/Cas9n-mediated genome editing strategy for ELANE-related severe congenital neutropenia
    Nasri, M.
    Ritter, M.
    Mir, P.
    Dannenmann, B.
    Kaufmann, M. M.
    Xu, Y.
    Borbaran-Bravo, N.
    Klimiankou, M.
    Lengerke, C.
    Zeidler, C.
    Cathomen, T.
    Welte, K.
    Skokowa, J.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A8 - A9
  • [6] CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
    Nasri, Masoud
    Ritter, Malte U.
    Mir, Perihan
    Dannenmann, Benjamin
    Kaufmann, Masako M.
    Arreba-Tutusaus, Patricia
    Xu, Yun
    Borbaran-Bravo, Natalia
    Klimiankou, Maksim
    Lengerke, Claudia
    Zeidler, Cornelia
    Cathomen, Toni
    Welte, Karl
    Skokowa, Julia
    MOLECULAR THERAPY, 2024, 32 (06) : 1628 - 1642
  • [7] Efficient Correction of ELANE mutations in Primary HSPCs of Severe Congenital Neutropenia Patients Using CRISPR/Cas9 and rAVV6 HDR Repair Templates
    Ritter, Malte U.
    Secker, Benjamin
    Klimiankou, Maksim
    Nasri, Masoud
    Aghaallaei, Narges
    Dannenmann, Benjamin
    Bernhard, Regine
    Steiert, Ingeborg
    Haehnel, Karin
    Bajoghli, Baubak
    Zeidler, Cornelia
    Welte, Karl
    Skokowa, Julia
    BLOOD, 2019, 134
  • [8] The CRISPR/Cas9 Genome Editing Revolution
    Renjie Jiao
    Caixia Gao
    Journal of Genetics and Genomics, 2016, 43 (05) : 227 - 228
  • [9] CRISPR/Cas9 genome editing in wheat
    Dongjin Kim
    Burcu Alptekin
    Hikmet Budak
    Functional & Integrative Genomics, 2018, 18 : 31 - 41
  • [10] CRISPR/Cas9 and Genome Editing in Drosophila
    Bassett, Andrew R.
    Liu, Ji-Long
    JOURNAL OF GENETICS AND GENOMICS, 2014, 41 (01) : 7 - 19